Pulsar Vascular: Pulsar Vascular obtains FDA IDE approval for PulseRider aneurysm neck reconstruction device

Pulsar Vascular has obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for its PulseRider aneurysm neck reconstruction device, designed to treat intracranial bifurcation aneurysms.